Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Army
Johnson and Johnson
Argus Health
Chinese Patent Office
Covington
McKesson
Accenture
Merck
Moodys

Generated: October 19, 2017

DrugPatentWatch Database Preview

SARENIN Drug Profile

« Back to Dashboard

What is the patent landscape for Sarenin, and what generic Sarenin alternatives are available?

Sarenin is a drug marketed by Procter And Gamble and is included in one NDA.

The generic ingredient in SARENIN is saralasin acetate. Additional details are available on the saralasin acetate profile page.

Summary for Tradename: SARENIN

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list4
Patent Applications: see list785
Drug Prices:see details
DailyMed Link:SARENIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Procter And Gamble
SARENIN
saralasin acetate
INJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: SARENIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Procter And Gamble
SARENIN
saralasin acetate
INJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Procter And Gamble
SARENIN
saralasin acetate
INJECTABLE;INJECTION018009-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Medtronic
Covington
Dow
Accenture
US Army
Harvard Business School
Moodys
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot